Cardiovascular disease
CVD is the leading cause of death in Spain, accounting for nearly 30% of all deaths. Genetically identifying at-risk individuals makes it possible to act before clinical symptoms appear.
Our cardiovascular genetic test assesses the highest-impact markers involved in the main pathologies associated with cardiovascular health, providing high-value information.
MyPrevention Cardio is a genetic test that determines the risk of a cardiovascular process, helping to better understand, prevent and manage conditions of the cardio-endothelial-metabolic system before symptoms appear.
It analyzes genetic markers with the highest level of scientific evidence, using innovative technology that offers greater precision and depth in the results.
Identifying at-risk individuals before symptoms appear is essential for preventing the morbidity and mortality associated with cardiovascular disease.
CVD is the leading cause of death in Spain, accounting for nearly 30% of all deaths. Genetically identifying at-risk individuals makes it possible to act before clinical symptoms appear.
A hereditary disease present from birth, characterized by elevated LDL-cholesterol levels. It makes it possible to guide treatment according to the causal gene and identify at-risk family members.
A sustained elevation of blood pressure. Knowing the genetic predisposition to hypertension allows the specialist to establish preventive guidelines and early monitoring in at-risk patients.
Deep vein thrombosis occurs when a clot forms in a deep vein. Thrombocythemia involves an elevated platelet count. Detecting the genetic predisposition makes it possible to adopt specific preventive measures.
The report provides genetic information of high clinical value for the prevention and personalized treatment of cardiovascular pathologies.
A simple, non-invasive process designed to fit into clinical practice.
The user receives instructions to correctly collect the sample.
DNA is obtained through a saliva sample, painlessly and non-invasively.
The sample is processed to analyze genetic markers related to cardiovascular health.
The report details the genetic predisposition to the main cardiovascular pathologies analyzed.
MyPrevention Cardio analyzes genetic markers selected for their high level of scientific evidence, using technology that offers greater precision and depth in the results.
Genetic markers selected for their demonstrated impact on cardiovascular pathologies.
Risk detection before symptoms appear, for early and effective intervention.
Identification of family members with shared genetic risk to extend prevention.
Genetic information that allows the specialist to adjust and personalize therapeutic strategies.
It is a cardiovascular genetic test that assesses genetic markers associated with the main pathologies of the cardiovascular system: cardiovascular disease, familial hypercholesterolemia, hypertension and thrombosis/thrombocythemia. It provides high-value information.
It is designed for medical specialists in the prevention, diagnosis and treatment of cardiovascular disease (primary care physicians, cardiologists, pediatricians). It is recommended for people with cardiovascular disease, clinical suspicion or a family history.
The sample is obtained non-invasively through saliva. It doesn’t require blood collection, is painless and suitable for anyone of any age.
No. Your genetics doesn’t change throughout life. The analysis is performed only once and the results remain valid permanently.
Once the sample is received at the lab, results are available within a maximum of 20 business days.
A blood test measures current values (cholesterol, pressure, etc.) that change over time. MyPrevention Cardio analyzes your genetic predisposition, which is permanent and makes it possible to get ahead of diseases before symptoms or abnormal lab results appear.
Contact our team for more information about MyPrevention Cardio or to request a cardiovascular genetic study.